There is hope (and need) for male contraception

Vasalgel and other new male contraceptives were highlighted in an article in The Telegraph. Written by Aaron Hamlin, the executive director of the Male Contraception Initiative, the piece offers hope that men and their partners will have more and better options for reproductive control in just a few years. The article points out that Vasalgel is poised to be the first approved male contraceptive since the condom. To stay up to date on Vasalgel’s development, sign up for our newsletters. Or consider a donation to Parsemus Foundation in support of Vasalgel.

Tell us what you think

This form does not collect your email address. If you would like us to respond, please send questions to
This field is for validation purposes and should be left unchanged.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today